Notizie

RANZCOG – What an incredible experience!

RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ — Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES, a home-use prenatal ultrasound platform that enables expectant mothers to perform guided scans at home interpreted by remote physicians.

RANZCOG – What an incredible experience! Read More »

CLALIT 2024 DEAL

Pulsenmore expands partnership with Clalit health services to deliver 25,000 home ultrasound devices for remote prenatal care

Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel’s largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to support Clalit’s commitment to accessible, high-quality prenatal care.

Pulsenmore expands partnership with Clalit health services to deliver 25,000 home ultrasound devices for remote prenatal care Read More »

Major milestone! Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer

Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore’s solution as part of its’ obstetrics department in the ‘Sheba Beyond virtual hospital, offering top-quality medical services to insured individuals across various health funds. Full article belowThe feature highlighted his achievements, showcasing his leadership and our collective efforts to make Pulsenmore a healthcare trailblazer.

Major milestone! Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer Read More »

Exciting news! Collaboration with Michigan Medicine

Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical burden.

Exciting news! Collaboration with Michigan Medicine Read More »